We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
Cap. Flow
+$11.3M
Cap. Flow %
2.61%
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.08M
2
SVC
Service Properties Trust
SVC
+$1.9M
3
PPL
PPL Corp
PPL
+$1.79M
4
CPT icon
Camden Property Trust
CPT
+$1.59M
5
DRE
Duke Realty Corp.
DRE
+$1.53M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.55M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.1M
3
BP icon
BP
BP
+$798K
4
XRX icon
Xerox
XRX
+$774K
5
AZN icon
AstraZeneca
AZN
+$716K

Sector Composition

Rank Sector Weight
1 Financials 15.83%
2 Technology 14.13%
3 Healthcare 12.38%
4 Energy 11.6%
5 Industrials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPG icon
126
Simon Property Group
SPG
$72.3B
$1.04M 0.24%
6,264
-346
-5% -$56.5K
R icon
127
Ryder
R
$10.1B
$1.02M 0.24%
11,637
-175
-1% -$14.7K
BCE icon
128
BCE
BCE
$21.2B
$1.02M 0.24%
22,504
– –
UNM icon
129
Unum
UNM
$14.3B
$1.02M 0.23%
29,261
+1,109
+4% +$37.9K
COST icon
130
Costco
COST
$420B
$1.02M 0.23%
8,820
-363
-4% -$41.6K
AGN
131
DELISTED
Allergan Inc
AGN
$1.01M 0.23%
5,984
+73
+1% +$11.4K
LOW icon
132
Lowe's Companies
LOW
$125B
$964K 0.22%
20,094
-607
-3% -$28.3K
DHR icon
133
Danaher
DHR
$144B
$953K 0.22%
18,015
-888
-5% -$45.6K
EMR icon
134
Emerson Electric
EMR
$88.3B
$936K 0.22%
14,105
+183
+1% +$12.3K
PSX icon
135
Phillips 66
PSX
$81.4B
$916K 0.21%
11,384
-257
-2% -$21.2K
MS icon
136
Morgan Stanley
MS
$340B
$911K 0.21%
28,174
+396
+1% +$12.2K
TMO icon
137
Thermo Fisher Scientific
TMO
$220B
$898K 0.21%
7,612
-477
-6% -$56.1K
TJX icon
138
TJX Companies
TJX
$178B
$875K 0.2%
32,934
-3,474
-10% -$99.1K
STX icon
139
Seagate
STX
$184B
$869K 0.2%
15,302
-1,586
-9% -$85.5K
MCK icon
140
McKesson
MCK
$101B
$866K 0.2%
4,653
-135
-3% -$24K
BNY
141
Bank of New York Mellon
BNY
$107B
$861K 0.2%
22,959
+473
+2% +$16.4K
APD icon
142
Air Products & Chemicals
APD
$67.6B
$853K 0.2%
7,170
-202
-3% -$22.5K
BAX icon
143
Baxter International
BAX
$14.2B
$850K 0.2%
21,656
-3,713
-15% -$149K
FDX icon
144
FedEx
FDX
$75.4B
$849K 0.2%
5,607
-119
-2% -$16.6K
KMB icon
145
Kimberly-Clark
KMB
$36.5B
$845K 0.19%
7,922
+92
+1% +$9.78K
D icon
146
Dominion Energy
D
$59.3B
$836K 0.19%
11,690
+182
+2% +$12.8K
TWC
147
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$825K 0.19%
5,601
+113
+2% +$15.9K
AA icon
148
Alcoa
AA
$13.2B
$818K 0.19%
22,850
+1,517
+7% +$49.7K
TEVA icon
149
Teva Pharmaceuticals
TEVA
$41.2B
$818K 0.19%
15,611
+544
+4% +$27.8K
SO icon
150
Southern Company
SO
$107B
$813K 0.19%
17,920
+327
+2% +$14.5K
4 5
6
7 8

Similar funds

BO
Bach Option Wanchai, Hong Kong $236M AUM 21.45% 1-Year Est. Return
GCA
Gideon Capital Advisors New York $291M AUM 28.95% 1-Year Est. Return
QCM
Quadrant Capital Management Fairfield, New Jersey $221M AUM 29.88% 1-Year Est. Return
AEPI
AH Equity Partners I Menlo Park, California $221M AUM
AC
Asturias Capital New York $220M AUM 39.56% 1-Year Est. Return
LA
Lau Associates Greenville, Delaware $201M AUM 26.29% 1-Year Est. Return
JFM
Jackson Financial Management Costa Mesa, California $194M AUM 21.54% 1-Year Est. Return
SHA
Shelter Harbor Advisors Weatogue, Connecticut $192M AUM 26.7% 1-Year Est. Return

ClearArc Capital's Q2 2014 Portfolio in Review

As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
  • ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
  • ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
  • ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
  • ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
  • ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
  • ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.

Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.